GSK’s Imigran Recovery Is First Triptan Approved For Nonprescription UK Sale

GlaxoSmithKline expects to make nonprescription Imigran Recovery (sumatriptan 50 mg) available in the UK in mid-June following approval for pharmacy sale by the Medicines & Healthcare products Regulatory Agency

More from Europe

More from Geography